Filing Details

Accession Number:
0000914190-16-000520
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-01-14 17:20:50
Reporting Period:
2016-01-12
Filing Date:
2016-01-14
Accepted Time:
2016-01-14 17:20:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1195116 Arno Therapeutics Inc ARNI Pharmaceutical Preparations (2834) 522286452
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1569002 B Steven Ruchefsky 200 Route 31 North
Suite 104
Flemington NJ 08822
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-01-12 2,876,633 $0.35 4,472,905 No 4 P Indirect By Commercial Street Capital, LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Commercial Street Capital, LLC
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option (right to buy) $8.00 2020-11-05 3,750 3,750 Direct
Common Stock Stock Option (right to buy) $2.40 2023-11-04 205,344 205,344 Direct
Common Stock Stock Option (right to buy) $2.90 2024-01-24 34,224 34,224 Direct
Common Stock Stock Option (right to buy) $0.85 2024-11-04 136,784 136,784 Direct
Common Stock Stock Option (right to buy) $0.36 2025-11-04 48,399 48,399 Direct
Common Stock 2012 Series A Warrants (right to buy) $1.36 2013-10-29 2017-11-26 1,531,861 1,531,861 Indirect
Common Stock 2013 Series D Warrants (right to buy) $2.14 2013-10-29 2018-10-29 1,285,046 1,285,046 Indirect
Expiration Date Amount Remaning Holdings Nature of Ownership
2020-11-05 3,750 3,750 Direct
2023-11-04 205,344 205,344 Direct
2024-01-24 34,224 34,224 Direct
2024-11-04 136,784 136,784 Direct
2025-11-04 48,399 48,399 Direct
2017-11-26 1,531,861 1,531,861 Indirect
2018-10-29 1,285,046 1,285,046 Indirect
Footnotes
  1. On January 12, 2016, Commercial Street Capital, LLC purchased 1,448,062 shares for cash consideration and was also issued 1,428,571 shares upon the automatic conversion of $506,821.92 of principal and accrued interest under a 6% unsecured convertible promissory note previously issued to Commercial Street Capital, LLC by the Issuer on October 21, 2015.
  2. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
  3. Currently exerciseable.
  4. Vests in equal 36-monthly installments commencing 12/4/13.
  5. Vests in equal 12-monthly installments commencing 2/24/14.
  6. Vests in equal 36-monthly installments commencing 12/4/14.
  7. Vests in equal 36-monthly installments commencing 12/4/15.
  8. As a result of the Issuer's 1/12/16 private placement of common stock at $0.35/share, the exercise price and number of shares subject to the 2012 Series A Warrants and 2013 Series D Warrants were automatically adjusted to the exercise price and shares reflected, pursuant to anti-dilution adjustment provisions.